DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $137,238,133 | +3.9% | 553,155 | +0.5% | 0.66% | +9.5% |
| Q2 2023 | $132,141,120 | -6.0% | 550,588 | -1.3% | 0.60% | -10.3% |
| Q1 2023 | $140,586,134 | -7.3% | 557,793 | -2.4% | 0.67% | -10.2% |
| Q4 2022 | $151,700,917 | +1.7% | 571,550 | -1.0% | 0.74% | -4.1% |
| Q3 2022 | $149,123,000 | +0.4% | 577,349 | -1.5% | 0.78% | +7.2% |
| Q2 2022 | $148,551,000 | -14.3% | 585,955 | -0.9% | 0.72% | -1.0% |
| Q1 2022 | $173,407,000 | -10.9% | 591,165 | -0.1% | 0.73% | -6.0% |
| Q4 2021 | $194,686,000 | +8.0% | 591,735 | -0.1% | 0.78% | -0.9% |
| Q3 2021 | $180,345,000 | +13.1% | 592,384 | -0.3% | 0.79% | +12.4% |
| Q2 2021 | $159,447,000 | -41.1% | 594,150 | -50.6% | 0.70% | +11.1% |
| Q1 2021 | $270,630,000 | +95.7% | 1,202,374 | +93.2% | 0.63% | -7.1% |
| Q4 2020 | $138,274,000 | -0.8% | 622,462 | -3.8% | 0.68% | -10.2% |
| Q3 2020 | $139,350,000 | +21.9% | 647,145 | +0.1% | 0.75% | +14.4% |
| Q2 2020 | $114,297,000 | +28.2% | 646,364 | +0.3% | 0.66% | +10.8% |
| Q1 2020 | $89,158,000 | -10.8% | 644,157 | -1.0% | 0.60% | +11.2% |
| Q4 2019 | $99,911,000 | +4.1% | 650,970 | -2.0% | 0.54% | -2.2% |
| Q3 2019 | $95,930,000 | +1.8% | 664,197 | +0.8% | 0.55% | -0.4% |
| Q2 2019 | $94,216,000 | +10.9% | 659,224 | +2.5% | 0.55% | +8.7% |
| Q1 2019 | $84,947,000 | +32.3% | 643,443 | +3.3% | 0.50% | +20.2% |
| Q4 2018 | $64,225,000 | -2.3% | 622,824 | +2.9% | 0.42% | +14.8% |
| Q3 2018 | $65,745,000 | +14.5% | 605,046 | +3.9% | 0.37% | +9.3% |
| Q2 2018 | $57,444,000 | +14.7% | 582,129 | +13.8% | 0.34% | +13.2% |
| Q1 2018 | $50,062,000 | +16.3% | 511,313 | +10.3% | 0.30% | +19.8% |
| Q4 2017 | $43,032,000 | +3.8% | 463,604 | -4.0% | 0.25% | +0.4% |
| Q3 2017 | $41,444,000 | -3.3% | 483,145 | -4.9% | 0.25% | -3.9% |
| Q2 2017 | $42,857,000 | -5.3% | 507,843 | -4.0% | 0.26% | -5.9% |
| Q1 2017 | $45,252,000 | +5.9% | 529,074 | -3.6% | 0.27% | +1.9% |
| Q4 2016 | $42,739,000 | -3.7% | 549,060 | -3.0% | 0.27% | -4.3% |
| Q3 2016 | $44,381,000 | -4.4% | 566,155 | -6.6% | 0.28% | -7.9% |
| Q2 2016 | $46,413,000 | -17.2% | 606,309 | +2.6% | 0.30% | -18.5% |
| Q1 2016 | $56,075,000 | +6.5% | 591,133 | +4.3% | 0.37% | +5.1% |
| Q4 2015 | $52,651,000 | +14.3% | 566,872 | +4.9% | 0.35% | +8.6% |
| Q3 2015 | $46,064,000 | +0.8% | 540,597 | +1.3% | 0.33% | +7.2% |
| Q2 2015 | $45,693,000 | +0.7% | 533,849 | -0.1% | 0.30% | +2.7% |
| Q1 2015 | $45,380,000 | -0.3% | 534,501 | +0.7% | 0.30% | -1.0% |
| Q4 2014 | $45,495,000 | +5.3% | 530,791 | -6.7% | 0.30% | +1.0% |
| Q3 2014 | $43,225,000 | -4.5% | 568,907 | -1.0% | 0.30% | -1.3% |
| Q2 2014 | $45,246,000 | +14.0% | 574,689 | +8.6% | 0.30% | -2.3% |
| Q1 2014 | $39,706,000 | +0.8% | 529,403 | +3.8% | 0.31% | +19.5% |
| Q4 2013 | $39,379,000 | +10.5% | 510,098 | -0.8% | 0.26% | +4.9% |
| Q3 2013 | $35,641,000 | -72.7% | 514,150 | -75.1% | 0.24% | -49.2% |
| Q2 2013 | $130,653,000 | +0.3% | 2,065,161 | -1.4% | 0.48% | 0.0% |
| Q1 2013 | $130,232,000 | +13.2% | 2,095,444 | +1.8% | 0.48% | +5.2% |
| Q4 2012 | $115,041,000 | – | 2,057,968 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |